Clinilabs is unique among providers of cardiac safety and cardiovascular drug development services. The Company provides ambulatory 12-lead ECG, Holter, blood pressure, fluid balance, and other assessments at its 60-bed, state-of-the-art Phase I unit that is outfitted with the most advanced cardiac safety equipment available today.
Clinilabs is unique among services providers in that it conducts cardiac safety studies (Thorough QT studies) and core ECG reading at the same location, giving sponsors the benefit of immediate, real-time data processing. With Clinilabs, no data is delayed or lost due to shipping problems.
Clinilabs core ECG laboratory and cardiac safety unit are supported by the latest Mortara Surveyor™ system, which is interfaced with validated ECG reading and management software.
|
